Page last updated: 2024-10-31

metronidazole and Glioblastoma

metronidazole has been researched along with Glioblastoma in 9 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research Excerpts

ExcerptRelevanceReference
"We used "high-dose" metronidazole, an "in vitro" and "in vivo" specific radiosensitizer of hypoxic cells, in a controlled trial to evaluate possible enhancement of radiation effect in patients with supratentorial glioblastomas."9.04Radiation and high-dose metronidazole in supratentorial glioblastomas. ( Band, P; Chapman, JD; Feldstein, ML; Fryer, C; Mielke, B; Urtasun, R, 1976)
"We used "high-dose" metronidazole, an "in vitro" and "in vivo" specific radiosensitizer of hypoxic cells, in a controlled trial to evaluate possible enhancement of radiation effect in patients with supratentorial glioblastomas."5.04Radiation and high-dose metronidazole in supratentorial glioblastomas. ( Band, P; Chapman, JD; Feldstein, ML; Fryer, C; Mielke, B; Urtasun, R, 1976)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, DJ2
Benoit, B1
Richard, MT1
Hugenholtz, H1
Dennery, J1
Russell, N1
Peterson, E1
Grahovac, Z1
Belanger, G1
Maroun, JA1
Gutin, PH1
Wara, WM1
Phillips, TL1
Wilson, CB1
Urtasun, R2
Feldstein, ML3
Partington, J1
Tanasichuk, H1
Miller, JD1
Russell, DB1
Agboola, O2
Mielke, B2
Dahrouge, S1
Girard, A1
Band, P1
Chapman, JD3
Fryer, C1
Belli, JA1
Hellman, S1
Urtasun, RC1
Band, PR1
Fowler, JF1

Reviews

1 review available for metronidazole and Glioblastoma

ArticleYear
Hypoxic sensitizers--implications for radiation therapy.
    The New England journal of medicine, 1979, Dec-27, Volume: 301, Issue:26

    Topics: Animals; Female; Glioblastoma; Humans; Metronidazole; Misonidazole; Neoplasms; Oxygen Consumption; R

1979

Trials

3 trials available for metronidazole and Glioblastoma

ArticleYear
Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
    British journal of cancer, 1982, Volume: 46, Issue:1

    Topics: Adult; Aged; Cerebellar Neoplasms; Clinical Trials as Topic; Glioblastoma; Humans; Metronidazole; Mi

1982
Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas.
    Journal of neuro-oncology, 1997, Volume: 32, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Brain Neoplasms; Cisplat

1997
Radiation and high-dose metronidazole in supratentorial glioblastomas.
    The New England journal of medicine, 1976, Jun-17, Volume: 294, Issue:25

    Topics: Administration, Oral; Adult; Aged; Brain Neoplasms; Cobalt Radioisotopes; Evaluation Studies as Topi

1976

Other Studies

5 other studies available for metronidazole and Glioblastoma

ArticleYear
Treatment of malignant gliomas in adults with BCNU plus metronidazole.
    Journal of neuro-oncology, 1984, Volume: 2, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carmustine; Female; Gliobl

1984
Hypoxic cell radiosensitizers in the treatment of malignant brain tumors.
    Neurosurgery, 1980, Volume: 6, Issue:5

    Topics: Animals; Brain Neoplasms; Cricetinae; DNA; Glioblastoma; Humans; Hypoxia; In Vitro Techniques; Metro

1980
Editorial: Hypoxic cell radiosensitizers.
    The New England journal of medicine, 1976, Jun-17, Volume: 294, Issue:25

    Topics: Brain Neoplasms; Glioblastoma; Male; Metronidazole; Oxygen; Radiation-Sensitizing Agents

1976
Radiation plus metronidazole for glioblastoma.
    The New England journal of medicine, 1977, Mar-31, Volume: 296, Issue:13

    Topics: Brain Neoplasms; Glioblastoma; Humans; Metronidazole; Radiation-Sensitizing Agents

1977
Developments in radiotherapy other than heavy particle beams.
    International journal of radiation oncology, biology, physics, 1977, Volume: 3

    Topics: Animals; Brain Neoplasms; Energy Transfer; Fast Neutrons; Female; Glioblastoma; Hot Temperature; Hum

1977